NanoViricides
NNVC
#10366
Rank
S$41.47 M
Marketcap
S$1.80
Share price
4.09%
Change (1 day)
1.03%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: S$41.47 Million

As of June 2026 NanoViricides has a market cap of S$41.47 Million. This makes NanoViricides the world's 10366th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026S$41.47 M25.86%
2025S$32.95 M12.65%
2024S$29.25 M84.87%
2023S$15.82 M-8.41%
2022S$17.27 M-70.19%
2021S$57.96 M43.14%
2020S$40.49 M209.16%
2019S$13.09 M-31.03%
2018S$18.98 M-74.53%
2017S$74.55 M-17.29%
2016S$90.13 M-6.61%
2015S$96.51 M-52.52%
2014S$0.20 B-33.2%
2013S$0.30 B232.6%
2012S$91.5 M-22.44%
2011S$0.11 B-55.11%
2010S$0.26 B66.96%
2009S$0.15 B10.74%
2008S$0.14 B112.56%
2007S$66.86 M

End of Day market cap according to different sources

On Jun 28th, 2026 the market cap of NanoViricides was reported to be:

S$39.83 Million
by Nasdaq info icon info icon
S$39.83 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
S$201.75 B 486,375.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$410.89 B 990,648.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$152.00 B 366,422.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$135.79 B 327,319.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
S$1.93 B 4,554.49%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$3.14 B 7,490.55%๐Ÿ‡บ๐Ÿ‡ธ USA